医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Oxea Announces Price Increase for n-Heptanoic Acid

2014年02月19日 PM04:25
このエントリーをはてなブックマークに追加


 

DALLAS

Oxea will increase list and off-list prices on the following product effective March 1, 2014, or as contracts allow. This price increase is due to recent raw material cost increases.

Product

     

North America
USD/lb

     

Europe
EUR/mt

     

ROW*
USD/mt

n-Heptanoic Acid       0.05       75       100
                 

* ROW = Rest of world

About Oxea

Oxea is a global manufacturer of oxo intermediates and oxo derivatives, such as alcohols, polyols, carboxylic acids, specialty esters, and amines. These products are used for the production of high-quality coatings, lubricants, cosmetics and pharmaceutical products, flavorings and fragrances, printing inks and plastics. In 2012, Oxea generated revenue of about EUR 1.5 billion with its over 1,400 employees worldwide. Oxea is owned by Oman Oil Company S.A.O.C.

For more information about Oxea, visit www.oxea-chemicals.com

About Oman Oil Company

Oman Oil Company S.A.O.C (OOC) is a commercial company wholly owned by the Government established in 1996 to pursue investment opportunities in the wider energy sector both inside and outside Oman. The Company plays an important role in the Sultanate’s efforts to diversify the economy and to promote domestic and foreign investments as well as fostering and building human capital.

CONTACT

Commercial contact:
OXEA GmbH, Otto-Roelen-Str. 3, D-46147
Oberhausen
Oliver Borgmeier, Global Marketing Manager Carboxylic
Acids
Phone: +49 208 693-2332
Fax: +49 208 693-2050
oliver.borgmeier@oxea-chemicals.com
www.oxea-chemicals.com
or
Press
contact:

Birgit Reichel
Phone: +49 208-693-3112
Fax:
+49 208-693-3101
birgit.reichel@oxea-chemicals.com
www.oxea-chemicals.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • レスメド後援の研究で在宅酸素療法と在宅非侵襲的換気療法の併用が費用対効果の高いCOPD治療法であると判明
  • Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of Clinical Oncology (ASCO) and the Congress of the European Hematology Association (EHA) Annual Meetings
  • Cerveau Technologies, Inc.与日本东京都老人综合研究所签订研究协议
  • 继美国和英国之后,中国向Personalis, Inc.签发ACE©技术专利,扩大了其在国际上的知名度
  • セルヴォー・テクノロジーズが日本の東京都健康長寿医療センター研究所と研究契約を締結